Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
•
Neuro-Oncology
•
Medical Oncology
•
CNS Disease
•
Drug Toxicity
Is it safe to give large fraction stereotactic irradiation for brain metastases concurrently with VEGF inhibitors?
Related Questions
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
What, if any, resources exist with recommendations regarding the timing and toxicity of radiation in patients who have received or are currently on immunotherapy?
What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?
How do you approach treatment of sub-total resected ZFTA fusion ependymoma after radiation therapy in a young adult?
For patients with metastatic cancer on a systemic therapy regimen that includes bevacizumab, are you comfortable treating brain metastases (SRS or WBRT) without holding bevacizumab?
What experience do you have with paralysis or myasthenia like symptoms developing on Temozolomide?
How would you manage a solitary unresectable liver metastasis?
How would you manage a patient less than 40 years old with an incidentally found LGG, IDH mutated, 1p19q intact, s/p STR?
Do you routinely prescribe memantine for patients who will be receiving hippocampal sparing whole brain RT if they are already on donepezil, or is donepezil alone sufficient?
Under what circumstances would you consider irradiation for brain metastases with active or recent bleeding?
